Protagonist Therapeutics, Inc. (PTGX)
103.75
+0.86
(+0.84%)
USD |
NASDAQ |
Apr 07, 16:00
103.66
-0.09
(-0.09%)
After-Hours: 20:00
Protagonist Therapeutics Cash from Investing (TTM) : -49.33M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Johnson & Johnson | -23.59B |
| AbbVie, Inc. | -6.643B |
| Insmed, Inc. | -64.58M |
| Madrigal Pharmaceuticals, Inc. | 32.32M |
| PTC Therapeutics, Inc. | -861.98M |